Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07850284 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders

Name: SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders — clinical trial record (NCT07850284)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseNot specified

SponsorMayo Clinic

Started2026-08-25

View on ClinicalTrials.gov ↗

Mayo Clinic

1,015 trials monitored

See 115 trials at risk

Multiple Myeloma

1,228 trials monitored

See 75 trials at risk

Amyloidosis

300 trials monitored

See 19 trials at risk

This study evaluates whether daily SMS-based (text messages) symptom monitoring is feasible and acceptable in patients who are undergoing treatment for multiple myeloma (MM) or systemic light chain amyloidosis (AL), and whether it can help in early identification of symptoms that may require clinical attention.

Trial Details

NCT Number	NCT07850284
Lead Sponsor	Mayo Clinic
Conditions	AL Amyloidosis, Multiple Myeloma
Enrollment	150 participants
Start Date	2026-08-25
Primary Completion	2028-08-25 (estimated)
Study Completion	2028-08-25 (estimated)
Updated on ClinicalTrials.gov	2026-09-30